TRT.L

Transense Technologies Plc
Transense Technlgy - Director/PDMR shareholding – acquisition of shares
1st August 2024, 09:35
TwitterFacebookLinkedIn
To continue viewing RNS, please confirm that you are a Private Investor*

* A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:

  1. Obtains access to the information in a personal capacity;
  2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
  3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
  4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
  5. Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
  6. Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
RNS Number : 8071Y
Transense Technologies PLC
01 August 2024
 

1 August 2024

 

Transense Technologies plc

("Transense" or the "Company")

 

Director/PDMR shareholding - acquisition of shares

 

Transense Technologies plc (AIM: TRT), the provider of specialist sensor technology and measurement systems, has been notified that on 31 July 2024, Melvyn Segal, Chief Financial Officer, purchased 4,761 ordinary shares of 10 pence each in the Company ("Ordinary Shares") at a price of 147 pence per share. Accordingly, Melvyn Segal 's total beneficial shareholding in the Company has increased to 73,529 Ordinary Shares, which represents approximately 0.48% of the Company's current voting rights.

 

Further details are provided in the form below in accordance with the requirements of the UK Market Abuse Regulation.

 

For further information please visit https://www.transense.com or contact:

 

Transense Technologies plc

Nigel Rogers (Executive Chairman)

Melvyn Segal (Chief Financial Officer)

Via Walbrook PR

Allenby Capital (Nominated Adviser and Broker)

Jeremy Porter/George Payne (Corporate Finance)

Stefano Aquilino/Tony Quirke (Sales and Corporate Broking)

Tel: +44 (0)20 3328 5656

Walbrook PR

Tom Cooper/Nick Rome/Joesph Walker

Tel: +44 (0)20 7933 8780

Transense@walbrookpr.com

Notes to Editors:

 

Transense is a developer of specialist sensor technology and measurement systems.  The Company has two active business divisions:

 

·    Translogik a range of smart, connected tyre inspection and management equipment, used by leading tyre manufacturers, dealers and fleet operators to reduce costs and improve safety; and

 

·    SAWsense, developing Surface Acoustic Wave (SAW) sensor technology, to improve performance, reliability and efficiency in focus markets of aerospace, automotive, robotics and industrial machinery.

 

In addition, the Company earns residual royalty income from Bridgestone iTrack (new branding name for iTrack), a tyre condition and performance monitoring system, that was developed by Translogik and subsequently licensed to Bridgestone Corporation for a ten-year period in 2020, expiring in 2030.

 

The Group's strategy is to maximise shareholder value through the delivery of sustained revenue growth from its business divisions by leveraging excellence in innovation and know-how to commercialise technologies through industry partnerships and exposure to global growth markets.

 

Transense is headquartered in Oxfordshire, UK, and was admitted to trading on AIM, a market operated by the London Stock Exchange (AIM: TRT), in 1999.  www.transense.com

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Melvyn Segal

2

 

Reason for the notification

a)

 

Position/status

 

 

Chief Financial Officer

b)

 

Initial notification /Amendment

 

Initial

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name 

 

Transense Technologies plc

b)

 

LEI

 

2138005N52J6KKQ3EY67

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares of 10 pence each



Identification code

GB00BDHDTH21



b)

 

Nature of the transaction 

 

Purchase of Ordinary Shares

c)

Price and volume

Price: 147 pence per share

 

Volume: 4,761

d)

 

Aggregated information


- Aggregated volume

As above

- Price




e)

 

Date of the transaction

 

31 July 2024

f)

 

Place of the transaction

 

London Stock Exchange, AIM

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHUPUWWRUPCUBG]]>
TwitterFacebookLinkedIn